Effect of telemonitoring on quality of life for patients with chronic obstructive pulmonary disease-A randomized controlled trial.

IF 3.5 3区医学 Q2 RESPIRATORY SYSTEM

Chronic Respiratory Disease Pub Date : 2023-01-01 DOI:10.1177/14799731231157771

Maria L Køpfli, Sanne Børgesen, Michael Skov Jensen, Charlotte Hyldgaard, Cathrine Bell, Frank D Andersen

{"title":"Effect of telemonitoring on quality of life for patients with chronic obstructive pulmonary disease-A randomized controlled trial.","authors":"Maria L Køpfli, Sanne Børgesen, Michael Skov Jensen, Charlotte Hyldgaard, Cathrine Bell, Frank D Andersen","doi":"10.1177/14799731231157771","DOIUrl":null,"url":null,"abstract":"Introduction: Patients with chronic obstructive pulmonary disease (COPD) often experience severe physical limitations and psychological distress, which can lead to a deterioration in quality of life (QoL). Telemonitoring (TM) may improve QoL and reduce the number of hospitalizations and readmissions, but results from previous studies have been conflicting. The aim of this study was to assess the effect of TM on QoL in patients with moderate to severe COPD recruited during hospitalization for acute exacerbation (AECOPD).Methods: We conducted a randomized controlled trial at Silkeborg and Viborg Regional Hospitals in Denmark. Participants were recruited during hospitalization for AECOPD and randomized to a six-month telemonitoring service in addition to standard COPD care or standard COPD care alone. Patients were followed for 24 months. QoL was measured by the Hospital Anxiety and Depression Scale (HADS), and St Georges Respiratory Questionnaire (SGRQ) at 3-, 6-, 12-, and 24-months follow-up. The main outcome was QoL at 6 months.Results: In total, 101 patients were randomized to the TM intervention and 97 to standard care. The between-group difference in SGRQ at 6 months was -2.0 (-8.5; 4.5), in HADS-Anxiety -0.3 (-2.0; 1.4) and in HADS-depression 0.2 (-1.0; 1.4) corresponding to no significant difference in health-related QoL for patients receiving TM compared to standard care. No difference was seen at 12-24 months follow-up either.Discussion: TM in addition to standard care did not improve QoL in patients with moderate to severe COPD. Other means of improving management and QoL in severe COPD are urgently needed.","PeriodicalId":10217,"journal":{"name":"Chronic Respiratory Disease","volume":"20 ","pages":"14799731231157771"},"PeriodicalIF":3.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/49/10.1177_14799731231157771.PMC9926364.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Respiratory Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/14799731231157771","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 1

Abstract

Introduction: Patients with chronic obstructive pulmonary disease (COPD) often experience severe physical limitations and psychological distress, which can lead to a deterioration in quality of life (QoL). Telemonitoring (TM) may improve QoL and reduce the number of hospitalizations and readmissions, but results from previous studies have been conflicting. The aim of this study was to assess the effect of TM on QoL in patients with moderate to severe COPD recruited during hospitalization for acute exacerbation (AECOPD).

Methods: We conducted a randomized controlled trial at Silkeborg and Viborg Regional Hospitals in Denmark. Participants were recruited during hospitalization for AECOPD and randomized to a six-month telemonitoring service in addition to standard COPD care or standard COPD care alone. Patients were followed for 24 months. QoL was measured by the Hospital Anxiety and Depression Scale (HADS), and St Georges Respiratory Questionnaire (SGRQ) at 3-, 6-, 12-, and 24-months follow-up. The main outcome was QoL at 6 months.

Results: In total, 101 patients were randomized to the TM intervention and 97 to standard care. The between-group difference in SGRQ at 6 months was -2.0 (-8.5; 4.5), in HADS-Anxiety -0.3 (-2.0; 1.4) and in HADS-depression 0.2 (-1.0; 1.4) corresponding to no significant difference in health-related QoL for patients receiving TM compared to standard care. No difference was seen at 12-24 months follow-up either.

Discussion: TM in addition to standard care did not improve QoL in patients with moderate to severe COPD. Other means of improving management and QoL in severe COPD are urgently needed.

Abstract Image

查看原文本刊更多论文

远程监护对慢性阻塞性肺疾病患者生活质量的影响——一项随机对照试验

慢性阻塞性肺疾病(COPD)患者经常经历严重的身体限制和心理困扰，这可能导致生活质量(QoL)的恶化。远程监护(TM)可以改善生活质量，减少住院和再入院的次数，但以往的研究结果相互矛盾。本研究的目的是评估TM对急性加重住院(AECOPD)期间招募的中重度COPD患者生活质量的影响。方法:我们在丹麦的Silkeborg和Viborg地区医院进行了一项随机对照试验。参与者在AECOPD住院期间被招募，并随机分配到六个月的远程监测服务，除了标准的COPD治疗或单独的标准COPD治疗。随访24个月。在随访3个月、6个月、12个月和24个月时，采用医院焦虑和抑郁量表(HADS)和St Georges呼吸问卷(SGRQ)测量生活质量。主要观察指标为6个月时的生活质量。结果:101例患者随机分为TM干预组，97例患者随机分为标准治疗组。6个月时SGRQ组间差异为-2.0 (-8.5;hads -焦虑组-0.3 (-2.0;1.4)， hads抑郁症为0.2 (-1.0;1.4)，与标准治疗相比，接受TM治疗的患者健康相关生活质量无显著差异。在12-24个月的随访中也没有发现差异。讨论:标准治疗之外的TM并没有改善中重度COPD患者的生活质量。迫切需要其他方法来改善重症COPD的管理和生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chronic Respiratory Disease RESPIRATORY SYSTEM-

CiteScore

5.90

自引率

7.30%

发文量

审稿时长

11 weeks

期刊介绍： Chronic Respiratory Disease is a peer-reviewed, open access, scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide. It publishes high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal provides a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.